| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/05/2001 | WO2001048117A1 Dry compositions containing hydrophobic amino acid |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047929A1 Triazolotriazinones and the use thereof |
| 07/05/2001 | WO2001047928A2 Imidazo 1,3,5 triazinones and the use thereof |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | WO2001047919A1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047899A1 Substituted piperazine derivatives as mtp inhibitors |
| 07/05/2001 | WO2001047897A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | WO2001047896A1 Benzimidazoles, production thereof and the use thereof as antithrombotic |
| 07/05/2001 | WO2001047874A1 (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| 07/05/2001 | WO2001047859A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | WO2001047548A1 Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation |
| 07/05/2001 | WO2001047547A1 Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy |
| 07/05/2001 | WO2001047533A2 INHIBITION OF GSK-3$g(b) |
| 07/05/2001 | WO2001047529A2 Association of deoxyfructosazine and an antidiabetic agonist of the peroxysome proliferator gamma-activated receptor |
| 07/05/2001 | WO2001047514A1 Use of hypoglycemic agent for treating impaired glucose metabolism |
| 07/05/2001 | WO2001047507A2 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/05/2001 | WO2001047506A2 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 07/05/2001 | WO2001047468A2 Association of deoxyfructosazine and an antidiabetic inhibiting alpha-glucosidase |
| 07/05/2001 | WO2001003720A9 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 07/05/2001 | WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2001000822A3 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 07/05/2001 | WO2000074650A3 Implantable gel compositions and method of manufacture |
| 07/05/2001 | WO2000073478A3 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000069896A3 Molecular interactions in haematopoietic cells |
| 07/05/2001 | WO2000068195A3 Substituted pyrrolidines as cell adhesion inhibitors |
| 07/05/2001 | US20010006957 Microdispersed or microfibrillar polyanhydroglucuronic acids and salts, complex salts or intermolecular polymer complexes suitable for fixing drug dosages with significantly protracted effect and reduced toxicity |
| 07/05/2001 | US20010006642 Delivering antigens or biologically active polypeptides to a subject in need of same by administering to the subject a non-invasive or non-pathogenic bacterium which expresses the antigens or polypeptides |
| 07/05/2001 | US20010006620 Such a hirudin or oral thrombin inhibitor, by determining from the ratio of the dose given to the measured ecarin clotting time using a computer statistical analysis program |
| 07/05/2001 | DE19963235A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 07/05/2001 | DE19962924A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 07/05/2001 | CA2396693A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | CA2396516A1 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395548A1 Imidazo 1,3,5 triazinones and the use thereof |
| 07/05/2001 | CA2395410A1 Triazolotriazinones and the use thereof |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/05/2001 | CA2394944A1 Combinations of a receptor tyrosine kinase inhibitor with an organic compound capable of binding to .alpha.1-acidic glycoprotein |
| 07/05/2001 | CA2394727A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | CA2394644A1 Substituted piperazine derivatives,the preparation thereof and their useas medicaments |
| 07/05/2001 | CA2393916A1 Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/04/2001 | EP1112286A1 Secreted proteins and polynucleotides encoding them |
| 07/04/2001 | EP1112266A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 07/04/2001 | EP1112088A1 Method for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
| 07/04/2001 | EP1112085A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 07/04/2001 | EP1112083A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 07/04/2001 | EP1112070A1 Novel substituted triazole compounds |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1301549A Method for producing chinese medicine for curing cardio-cerebrol vascular disease |
| 07/04/2001 | CN1067898C Blood platelet regenerating pills and its preparation method |
| 07/04/2001 | CN1067891C Traditional Chinese medicine for curing cerebral thrambus |
| 07/04/2001 | CN1067881C Hemostatic powder |
| 07/03/2001 | US6255468 MPROT12 polynucleotides and methods thereof |
| 07/03/2001 | US6255348 Use of aminoadamantane compounds as immunoregulators |
| 07/03/2001 | US6255301 Amino acid derivatives and their use as thrombin inhibitors |
| 07/03/2001 | US6255281 Complexing uteroglobin to fibronectin |
| 07/03/2001 | US6255277 Localized use of nitric oxide-adducts to prevent internal tissue damage |
| 07/03/2001 | US6254870 Amino acid sequences |
| 07/03/2001 | CA2141704C Concentrated aqueous argatroban solutions |
| 07/03/2001 | CA2132512C Bioadhesive pharmaceutical composition used for the controlled release of active ingredient |
| 07/03/2001 | CA2075901C Tissue plasminogen activator having fibrin specific properties |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/28/2001 | WO2001046475A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046422A1 Novel cytokine zcyto18 |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046254A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046218A2 Fragments of pf4 and pharmaceutical compositions containing the same |
| 06/28/2001 | WO2001046183A1 SUBSTITUTED 1,3,4-OXADIAZOLES AND A METHOD OF REDUCING TNF-α LEVELS |
| 06/28/2001 | WO2001046151A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/28/2001 | WO2001046136A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 06/28/2001 | WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | WO2001045751A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | WO2001045741A2 Methods for preparing pharmaceutical formulations |
| 06/28/2001 | WO2001045733A1 Carbonyl stress-ameliorating agents |
| 06/28/2001 | WO2001045713A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method |
| 06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | WO2001045641A2 Inhibitors of thrombin induced platelet aggregation |
| 06/28/2001 | WO2001045510A1 Adeno-associated vectors for expression of factor viii by target cells |
| 06/28/2001 | WO2001005414A8 Algae protein polysaccharide extraction and use thereof |
| 06/28/2001 | WO2000078776A3 Thiophene a2a receptor agonists |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO1997046686A3 Tumor necrosis factor-related polypeptide |
| 06/28/2001 | DE19962329A1 New substituted 2-(phenylaminomethyl)-benzimidazoles, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates |
| 06/28/2001 | DE19959049A1 Kombination von Verbindungen, welche die biologischen Wirkungen von TNF-alpha und CD95L hemmen Combination of compounds, which inhibit the biological effects of TNF-alpha and CD95L |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395202A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |